Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1998 Jan;93(1):1–10. doi: 10.1046/j.1365-2567.1998.00401.x

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

M Ryan 1, G Murphy 1, E Ryan 1, L Nilsson 1, F Shackley 1, L Gothefors 1, K Oymar 1, E Miller 1, J Storsaeter 1, K H Mills 1
PMCID: PMC1364099  PMID: 9536112

Abstract

Recent clinical trials have demonstrated that new generation acellular pertussis vaccines can confer protection against whooping cough. However, the mechanism of protective immunity against Bordetella pertussis infection induced by vaccination remains to be defined. We have examined cellular immune responses in children immunized with a range of acellular and whole cell pertussis vaccines. Immunization of children with a potent whole-cell vaccine induced B. pertussis-specific T cells that secreted interferon-gamma (IFN-gamma), but not interleukin-5 (IL-5). In contrast, T cells from children immunized with acellular pertussis vaccines secreted IFN-gamma and/or IL-5 following stimulation with B. pertussis antigens in vitro. These observations suggest that protective immunity conferred by whole-cell vaccines, like natural immunity, is mediated by type 1 T cells, whereas the mechanism of immune protection generated with acellular vaccines may be more heterogeneous, involving T cells that secreted type 1 and type 2 cytokines.

Full text

PDF
1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbas A. K., Murphy K. M., Sher A. Functional diversity of helper T lymphocytes. Nature. 1996 Oct 31;383(6603):787–793. doi: 10.1038/383787a0. [DOI] [PubMed] [Google Scholar]
  2. Barnard A., Mahon B. P., Watkins J., Redhead K., Mills K. H. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology. 1996 Mar;87(3):372–380. doi: 10.1046/j.1365-2567.1996.497560.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bromberg K., Tannis G., Steiner P. Detection of Bordetella pertussis associated with the alveolar macrophages of children with human immunodeficiency virus infection. Infect Immun. 1991 Dec;59(12):4715–4719. doi: 10.1128/iai.59.12.4715-4719.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cassone A., Ausiello C. M., Urbani F., Lande R., Giuliano M., La Sala A., Piscitelli A., Salmaso S. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Arch Pediatr Adolesc Med. 1997 Mar;151(3):283–289. doi: 10.1001/archpedi.1997.02170400069013. [DOI] [PubMed] [Google Scholar]
  5. Edwards K. M., Meade B. D., Decker M. D., Reed G. F., Rennels M. B., Steinhoff M. C., Anderson E. L., Englund J. A., Pichichero M. E., Deloria M. A. Comparison of 13 acellular pertussis vaccines: overview and serologic response. Pediatrics. 1995 Sep;96(3 Pt 2):548–557. [PubMed] [Google Scholar]
  6. Greco D., Salmaso S., Mastrantonio P., Giuliano M., Tozzi A. E., Anemona A., Ciofi degli Atti M. L., Giammanco A., Panei P., Blackwelder W. C. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. N Engl J Med. 1996 Feb 8;334(6):341–348. doi: 10.1056/NEJM199602083340601. [DOI] [PubMed] [Google Scholar]
  7. Gustafsson L., Hallander H. O., Olin P., Reizenstein E., Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med. 1996 Feb 8;334(6):349–355. doi: 10.1056/NEJM199602083340602. [DOI] [PubMed] [Google Scholar]
  8. Isacson J., Trollfors B., Taranger J., Lagergård T. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Pediatr Infect Dis J. 1995 Jun;14(6):517–521. doi: 10.1097/00006454-199506000-00009. [DOI] [PubMed] [Google Scholar]
  9. Mahon B. P., Katrak K., Nomoto A., Macadam A. J., Minor P. D., Mills K. H. Poliovirus-specific CD4+ Th1 clones with both cytotoxic and helper activity mediate protective humoral immunity against a lethal poliovirus infection in transgenic mice expressing the human poliovirus receptor. J Exp Med. 1995 Apr 1;181(4):1285–1292. doi: 10.1084/jem.181.4.1285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mahon B. P., Ryan M. S., Griffin F., Mills K. H. Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells. Infect Immun. 1996 Dec;64(12):5295–5301. doi: 10.1128/iai.64.12.5295-5301.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miller E., Ashworth L. A., Redhead K., Thornton C., Waight P. A., Coleman T. Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance. Vaccine. 1997 Jan;15(1):51–60. doi: 10.1016/s0264-410x(96)00112-0. [DOI] [PubMed] [Google Scholar]
  12. Mills K. H., Barnard A., Watkins J., Redhead K. Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model. Infect Immun. 1993 Feb;61(2):399–410. doi: 10.1128/iai.61.2.399-410.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Mills K. H., Redhead K. Cellular immunity in pertussis. J Med Microbiol. 1993 Sep;39(3):163–164. doi: 10.1099/00222615-39-3-163. [DOI] [PubMed] [Google Scholar]
  14. Peppoloni S., Nencioni L., Di Tommaso A., Tagliabue A., Parronchi P., Romagnani S., Rappuoli R., De Magistris M. T. Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun. 1991 Oct;59(10):3768–3773. doi: 10.1128/iai.59.10.3768-3773.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Petersen J. W., Andersen P., Ibsen P. H., Capiau C., Wachmann C. H., Hasløv K., Heron I. Proliferative responses to purified and fractionated Bordetella pertussis antigens in mice immunized with whole-cell pertussis vaccine. Vaccine. 1993;11(4):463–472. doi: 10.1016/0264-410x(93)90289-a. [DOI] [PubMed] [Google Scholar]
  16. Petersen J. W., Ibsen P. H., Bentzon M. W., Capiau C., Heron I. The cell mediated and humoral immune response to vaccination with acellular and whole cell pertussis vaccine in adult humans. FEMS Microbiol Immunol. 1991 Oct;3(5):279–287. doi: 10.1111/j.1574-6968.1991.tb04224.x. [DOI] [PubMed] [Google Scholar]
  17. Podda A., Nencioni L., De Magistris M. T., Di Tommaso A., Bossù P., Nuti S., Pileri P., Peppoloni S., Bugnoli M., Ruggiero P. Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med. 1990 Sep 1;172(3):861–868. doi: 10.1084/jem.172.3.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Redhead K., Watkins J., Barnard A., Mills K. H. Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity. Infect Immun. 1993 Aug;61(8):3190–3198. doi: 10.1128/iai.61.8.3190-3198.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ryan M., Murphy G., Gothefors L., Nilsson L., Storsaeter J., Mills K. H. Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells. J Infect Dis. 1997 May;175(5):1246–1250. doi: 10.1086/593682. [DOI] [PubMed] [Google Scholar]
  20. Saukkonen K., Cabellos C., Burroughs M., Prasad S., Tuomanen E. Integrin-mediated localization of Bordetella pertussis within macrophages: role in pulmonary colonization. J Exp Med. 1991 May 1;173(5):1143–1149. doi: 10.1084/jem.173.5.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Simondon F., Preziosi M. P., Yam A., Kane C. T., Chabirand L., Iteman I., Sanden G., Mboup S., Hoffenbach A., Knudsen K. A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal. Vaccine. 1997 Oct;15(15):1606–1612. doi: 10.1016/s0264-410x(97)00100-x. [DOI] [PubMed] [Google Scholar]
  22. Trollfors B., Taranger J., Lagergård T., Lind L., Sundh V., Zackrisson G., Lowe C. U., Blackwelder W., Robbins J. B. A placebo-controlled trial of a pertussis-toxoid vaccine. N Engl J Med. 1995 Oct 19;333(16):1045–1050. doi: 10.1056/NEJM199510193331604. [DOI] [PubMed] [Google Scholar]
  23. Wiertz E. J., Loggen H. G., Walvoort H. C., Kreeftenberg J. G. In vitro induction of antigen specific antibody synthesis and proliferation of T lymphocytes with acellular pertussis vaccines, pertussis toxin and filamentous haemagglutinin in humans. J Biol Stand. 1989 Apr;17(2):181–190. doi: 10.1016/0092-1157(89)90008-5. [DOI] [PubMed] [Google Scholar]
  24. Zepp F., Knuf M., Habermehl P., Schmitt J. H., Rebsch C., Schmidtke P., Clemens R., Slaoui M. Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun. 1996 Oct;64(10):4078–4084. doi: 10.1128/iai.64.10.4078-4084.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES